Tag: Ischemic Stroke
-
Inflammatory Biomarkers and Ischemic Stroke: Paving the Path to Precision Medicine
Ischemic stroke remains a leading cause of disability and death worldwide. While rapid reperfusion therapies save lives, the broader story of recovery and long‑term function now increasingly hinges on the inflammatory response following cerebral ischemia. Inflammatory biomarkers—measurable indicators of the body’s immune and inflammatory activity—are emerging as linchpins for precision medicine in ischemic stroke. By…
-
Inflammatory Biomarkers and the Path to Precision Medicine in Ischemic Stroke
Understanding the Dual Role of Inflammation in Ischemic Stroke Ischemic stroke occurs when a blood clot blocks a vessel, cutting off blood flow to parts of the brain. The resulting cascade includes an inflammatory response that can both harm and help recovery. On one hand, excessive inflammation can exacerbate neuronal injury, disrupt the blood-brain barrier,…
-
Inflammatory biomarkers and precision medicine in ischemic stroke: paving the way for targeted care
Understanding the role of inflammation in ischemic stroke Ischemic stroke occurs when a blood clot blocks an artery, depriving brain tissue of oxygen and nutrients. The ensuing cascade triggers inflammation, a double-edged sword in stroke biology. On one hand, inflammatory responses help clear debris and promote repair. On the other, excessive or misdirected inflammation can…
-
Surgical Left Atrial Appendage Occlusion: No Clear Benefits in Non-AF Patients
Recent research has stirred discussions surrounding the efficacy of surgical left atrial appendage (LAA) occlusion in non-atrial fibrillation (AF) patients undergoing valve surgery. Traditionally, LAA occlusion is implemented in patients with AF to mitigate the risk of stroke, transient ischemic attacks (TIA), and cardiovascular mortality. However, findings from a comprehensive study reveal that this approach…